MedTrace Logo

Breast Cancer Survivorship Biorepository

NCT05786664 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1300

Last updated 2025-12-04

No results posted yet for this study

Summary

This study collects blood samples as well as clinical and self-report data from stage I-III breast cancer survivors to create a biorepository for future use. The creation of this biorepository will allow for future research into links between individual, molecular, and genomic signatures and cancer outcomes.

Conditions

  • Anatomic Stage I Breast Cancer AJCC v8
  • Anatomic Stage II Breast Cancer AJCC v8
  • Anatomic Stage III Breast Cancer AJCC v8
  • Invasive Breast Carcinoma

Interventions

OTHER

Quality-of-Life Assessment

Complete quality-of-life questionnaires

OTHER

Survey Administration

Complete surveys

PROCEDURE

Biospecimen Collection

Undergo collection of blood samples

OTHER

Electronic Health Record Review

Review of records

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • University of Southern California

    lead OTHER

Principal Investigators

  • Bodour Salhia, PhD · University of Southern California

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-11
Primary Completion
2027-04-11
Completion
2028-04-11

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05786664 on ClinicalTrials.gov